SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-012065
Filing Date
2019-08-12
Accepted
2019-08-12 15:53:53
Documents
54
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 596743
2 ex31-1.htm EX-31.1 20116
3 ex31-2.htm EX-31.2 20117
4 ex32-1.htm EX-32.1 7943
5 ex32-2.htm EX-32.2 7838
  Complete submission text file 0001493152-19-012065.txt   3360853

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE prph-20190630.xml EX-101.INS 615655
7 XBRL SCHEMA FILE prph-20190630.xsd EX-101.SCH 47245
8 XBRL CALCULATION FILE prph-20190630_cal.xml EX-101.CAL 51350
9 XBRL DEFINITION FILE prph-20190630_def.xml EX-101.DEF 124484
10 XBRL LABEL FILE prph-20190630_lab.xml EX-101.LAB 300235
11 XBRL PRESENTATION FILE prph-20190630_pre.xml EX-101.PRE 206841
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 191016367
SIC: 2834 Pharmaceutical Preparations